Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2
Introduction 8
2.1 What Is This Report About? 8
3 Definitions of the
Markets Covered in the Report 9
3.1 Drug delivery devices 9
3.2
Inhalation Systems 9
3.2.1 Metered Dose Inhaler 9
3.2.2 Dry powder
inhaler 9
3.3 Infusion Systems 9
3.3.1 Infusion pumps 9
3.3.2
Syringe pumps 9
3.3.3 Disposable Infusion sets 10
4 Healthcare Sector
Review 11
4.1 Healthcare Expenditure 11
4.2 Healthcare Infrastructure
14
4.3 Healthcare Policy 18
5 Regulation System 19
5.1 Medical
Equipment Approval Process 19
5.1.1 Classification 19
5.1.2 Premarket
Notification for Class I Devices 20
5.1.3 Pre-market Approval for Class
II, III and IV Devices 20
5.1.4 License Fee 21
5.1.5 License
Application Processing Duration 21
5.2 Post-market Surveillance 22
6
Pricing and Reimbursement 23
7 Distribution Structure 26
7.1
Distribution Structure 26
8 Drug Delivery Devices In Republic of Korea
27
8.1 Drug Delivery Devices Cross Country Comparison (2000-2012) 27
8.2 Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn),
2000-2012 28
8.3 Drug Delivery Devices, Republic of Korea, Category Volume
(Units), 2000-2012 32
8.4 Drug Delivery Devices, Republic of Korea,
Company Share (2006-2007) 35
9 Infusion Systems In Republic of Korea
36
9.1 Infusion Systems Overall Revenue (2000-2012) 36
9.2 Infusion
Systems Overall Volume (2000-2012) 38
9.3 Infusion Systems Average Price
(2000-2012) 39
9.4 Infusion Systems Distribution Share (2006-2007) 40
9.5 Infusion Systems, Republic of Korea, Company Share (2006-2007) 41
10
Inhalation Systems In Republic of Korea 42
10.1 Inhalation Systems Overall
Revenue (2000-2012) 42
10.2 Inhalation Systems Overall Volume (2000-2012)
44
10.3 Inhalation Systems Average Price (2000-2012) 46
10.4
Inhalation Systems Distribution Share (2006-2007) 47
10.5 Inhalation
Systems, Republic of Korea, Company Share (2006-2007) 48
11 3M Company
Company Profile 49
11.1 Company Overview 49
11.2 Value Chain Analysis
49
11.2.1 Manufacturing 50
11.2.2 Product Development 50
11.2.3
Sales and Marketing 51
12 AstraZeneca PLC Company Profile 52
12.1
Company Overview 52
13 GlaxoSmithKline plc Company Profile 53
13.1
Company Overview 53
14 Boehringer Ingelheim GmbH Company Profile 54
14.1 Company Overview 54
14.2 Value Chain Analysis 54
14.2.1
Manufacturing 55
14.2.2 Product Development 55
14.2.3 Sales and
Marketing 56
15 Novartis Medical Nutrition Company Profile 57
15.1
Company Overview 57
16 Cardinal Health, Inc. Company Profile 58
16.1
Company Overview 58
16.2 Value Chain Analysis 58
16.2.1 Manufacturing
59
16.2.2 Product Development 59
16.2.3 Sales and Marketing 60
17
Samyang Corporation Company Profile 61
17.1 Company Overview 61
18
Shin Chang Medical Co., Ltd. Company Profile 62
18.1 Company Overview
62
19 Woo Young Medical Co., Ltd. Company Profile 63
19.1 Company
Overview 63
20 Appendix 64
20.1 Global Markets Direct Research
Methodology 64
20.2 Coverage 65
20.3 Secondary Research 65
20.4
Primary Research 66
20.5 Models 66
20.6 Forecasts 67
20.7 Expert
Panels 67
20.8 Currency Conversion 68
20.9 Contact Us 69
20.10
Disclaimer 69
1.1 List of Tables
Table 1: Hospital Wards by
Specialty in Republic of Korea, 2003-2007 15
Table 2: Doctors by Specialty
in Republic of Korea, 2003-2007 16
Table 3: Healthcare Institutions in
Republic of Korea, 2001-2005 17
Table 4: Healthcare Personnel in Republic
of Korea, 1975-2002 17
Table 5: Classification of Medical Equipment in
Republic of Korea 19
Table 6: Drug Delivery Devices Cross Country
Comparison (2000-2012) 27
Table 7: Drug Delivery Devices, Republic of
Korea, Overall Revenues ($ mn), 2000-2012 28
Table 8: Drug Delivery
Devices, Republic of Korea, Portfolio Analysis, 2000-2012 29
Table 9:
Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), Historic,
2000-2007 30
Table 10: Drug Delivery Devices, Republic of Korea,
Overall Revenues ($ mn), Forecast, 2007-2012 31
Table 11: Drug
Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2012 32
Table 12: Drug Delivery Devices, Republic of Korea, Category Volume
(Units), Historic, 2000-2007 33
Table 13: Drug Delivery Devices,
Republic of Korea, Category Volume (Units), Forecast, 2007-2012 34
Table
14: Drug Delivery Devices, Republic of Korea, Company Share by Revenue ($
mn), 2006-2007 35
Table 15: Infusion Systems, Republic of Korea,
Revenue ($ mn) by Segment, Historic, 2000-2007 36
Table 16: Infusion
Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012
37
Table 17: Infusion Systems, Republic of Korea, Overall Volume
(Units), Historic, 2000-2007 38
Table 18: Infusion Systems, Republic
of Korea, Overall Volume (Units), Forecast, 2007-2012 38
Table 19:
Infusion Systems, Republic of Korea, Average Price ($), Historic, 2000-2007
39
Table 20: Infusion Systems, Republic of Korea, Average Price ($),
Forecast, 2007-2012 39
Table 21: Infusion Systems, Republic of Korea,
Distribution Share by Revenue ($mn), 2006-2007 40
Table 22: Infusion
Systems, Republic of Korea, Company Share by Revenue ($ mn), 2006-2007 41
Table 23: Inhalation Systems, Republic of Korea, Revenue ($ mn) by
Segment, Historic, 2000-2007 42
Table 24: Inhalation Systems, Republic
of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 43
Table 25:
Inhalation Systems, Republic of Korea, Overall Volume (Units), Historic,
2000-2007 44
Table 26: Inhalation Systems, Republic of Korea, Overall
Volume (Units), Forecast, 2007-2012 45
Table 27: Inhalation Systems,
Republic of Korea, Average Price ($), Historic, 2000-2007 46
Table 28:
Inhalation Systems, Republic of Korea, Average Price ($), Forecast, 2007-2012
46
Table 29: Inhalation Systems, Republic of Korea, Distribution
Share by Revenue ($mn), 2006-2007 47
Table 30: Inhalation Systems,
Republic of Korea, Company Share by Revenue ($ mn), 2006-2007 48
Table 31:
Currency Conversion from USD to Local Currency at 2007 Constant Rate 68
1.2 List of Figures
Figure 1: Healthcare Financing in Republic of
Korea, 2007 12
Figure 2: Healthcare Expenditure in Republic of Korea, 2000
- 2006 13
Figure 3: Evaluation (Value Appraisal) Criteria for Medical
Device Reimbursement in Republic of Korea, 2007 24
Figure 4: Medical
Device Pricing System in Republic of Korea, 2007 25
Figure 5: Drug
Delivery Devices Cross Country Comparison (2000-2012) 27
Figure 6:
Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012
28
Figure 7: Drug Delivery Devices, Republic of Korea, Portfolio Analysis,
2000-2012 29
Figure 8: Drug Delivery Devices, Republic of Korea,
Overall Revenues ($ mn), Historic, 2000-2007 30
Figure 9: Drug
Delivery Devices, Republic of Korea, Overall Revenues ($ mn), Forecast,
2007-2012 31
Figure 10: Drug Delivery Devices, Republic of Korea,
Category Volume (Units), 2000-2012 32
Figure 11: Drug Delivery
Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2007
33
Figure 12: Drug Delivery Devices, Republic of Korea, Category
Volume (Units), Forecast, 2007-2012 34
Figure 13: Drug Delivery
Devices, Republic of Korea, Company Share (%), 2007 35
Figure 14:
Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic,
2000-2007 36
Figure 15: Infusion Systems, Republic of Korea, Revenue
($ mn) by Segment, Forecast, 2007-2012 37
Figure 16: Infusion
Systems, Republic of Korea, Company Share (%), 2007 41
Figure 17:
Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic,
2000-2007 42
Figure 18: Inhalation Systems, Republic of Korea, Revenue
($ mn) by Segment, Forecast, 2007-2012 43
Figure 19: Inhalation
Systems, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 44
Figure 20: Inhalation Systems, Republic of Korea, Overall Volume (Units),
Forecast, 2007-2012 45
Figure 21: Inhalation Systems, Republic of
Korea, Company Share (%), 2007 48
Figure 22: 3M Healthcare Value
Chain Analysis 49
Figure 23: Boehringer Ingelheim GmbH Value Chain
Analysis 54
Figure 24: Cardinal Health, Inc. Value Chain Analysis
58
Figure 25: Global Markets Direct Methodology 64
|
Related Report
|
View Cart
